ioxaglate has been researched along with Diabetic Nephropathies in 3 studies
Ioxaglic Acid: A low-osmolar, ionic contrast medium used in various radiographic procedures.
ioxaglic acid : A benzenedicarboxamide compound having N-substituted carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and an acetyl(methyl)amino group at the 5-position.
Diabetic Nephropathies: KIDNEY injuries associated with diabetes mellitus and affecting KIDNEY GLOMERULUS; ARTERIOLES; KIDNEY TUBULES; and the interstitium. Clinical signs include persistent PROTEINURIA, from microalbuminuria progressing to ALBUMINURIA of greater than 300 mg/24 h, leading to reduced GLOMERULAR FILTRATION RATE and END-STAGE RENAL DISEASE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Four patients reacting with acute renal failure despite using low osmolar contrast media are reported." | 1.28 | Acute renal failure caused by low-osmolar radiographic contrast media in patients with diabetic nephropathy. ( Larsson, R; Lundberg, M; Nikonoff, T; Nyberg, P; Skau, T; Spångberg-Viklund, B, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dussol, B | 1 |
| Morange, S | 1 |
| Loundoun, A | 1 |
| Auquier, P | 1 |
| Berland, Y | 1 |
| Narasaki, K | 1 |
| Spångberg-Viklund, B | 1 |
| Nikonoff, T | 1 |
| Lundberg, M | 1 |
| Larsson, R | 1 |
| Skau, T | 1 |
| Nyberg, P | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Efficacy of Oral Sodium Chloride vs iv Sodium Chloride in the Prevention of Contrast Nephropathy in Outpatients[NCT03476460] | Phase 2 | 269 participants (Actual) | Interventional | 2014-03-01 | Completed | ||
| Intravenous vs. Oral Hydration to Reduce the Risk of Post-Contrast Acute Kidney Injury After Intravenous Contrast-Enhanced Computed Tomography in Patients With Severe Chronic Kidney Disease (ENRICH): A Randomized Controlled Trial[NCT05283512] | 254 participants (Anticipated) | Interventional | 2022-04-20 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for ioxaglate and Diabetic Nephropathies
| Article | Year |
|---|---|
A randomized trial of saline hydration to prevent contrast nephropathy in chronic renal failure patients.
Topics: Administration, Oral; Aged; Contrast Media; Creatinine; Diabetic Nephropathies; Diuretics; Drug Syne | 2006 |
A randomized trial of saline hydration to prevent contrast nephropathy in chronic renal failure patients.
Topics: Administration, Oral; Aged; Contrast Media; Creatinine; Diabetic Nephropathies; Diuretics; Drug Syne | 2006 |
A randomized trial of saline hydration to prevent contrast nephropathy in chronic renal failure patients.
Topics: Administration, Oral; Aged; Contrast Media; Creatinine; Diabetic Nephropathies; Diuretics; Drug Syne | 2006 |
A randomized trial of saline hydration to prevent contrast nephropathy in chronic renal failure patients.
Topics: Administration, Oral; Aged; Contrast Media; Creatinine; Diabetic Nephropathies; Diuretics; Drug Syne | 2006 |
2 other studies available for ioxaglate and Diabetic Nephropathies
| Article | Year |
|---|---|
[Contrast-associated nephrotoxicity: ultrastructural and biochemical study in diabetic rats].
Topics: Animals; Contrast Media; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Diatrizoate; Iopam | 1997 |
Acute renal failure caused by low-osmolar radiographic contrast media in patients with diabetic nephropathy.
Topics: Acute Kidney Injury; Adult; Aged; Angiography; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Fe | 1989 |